Nature Reviews Clinical Oncology
Vol. 23, Issue 3
Issue 3
2026
10
Articles
Articles in this Issue
Author Correction: Advances in the management of localized bladder cancers
Marie-Pier St-Laurent, Jussi Nikkola, Eisuke Tomiyama et al.
Mar 01, 2026
pp. 230-230
10.1038/s41571-026-01121-6
A guide to cancer screening
Stephen W. Duffy, Judith Offman
Mar 01, 2026
pp. 201-212
10.1038/s41571-025-01112-z
Base-edited CAR7 T cells are safe and efficacious in R/R T-ALL
Diana Romero
Mar 01, 2026
pp. 152-152
10.1038/s41571-025-01118-7
Discovery of predictive biomarkers for cancer therapy through computational approaches
Xin Wang, Julia Nguyen, Kristen Nader et al.
Mar 01, 2026
pp. 180-200
10.1038/s41571-025-01109-8
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology
Amber Johnson, Yifei Shen, Xiaofeng Zheng et al.
Mar 01, 2026
pp. 213-229
10.1038/s41571-025-01110-1
Advances in the management of localized bladder cancers
Marie-Pier St-Laurent, Jussi Nikkola, Eisuke Tomiyama et al.
Mar 01, 2026
pp. 158-179
10.1038/s41571-025-01104-z
Vebreltinib effective in MET-amplified NSCLC
Peter Sidaway
Mar 01, 2026
pp. 151-151
10.1038/s41571-025-01117-8
MajesTEC results with teclistamab in relapsed and/or refractory multiple myeloma
David Killock
Mar 01, 2026
pp. 151-151
10.1038/s41571-025-01116-9
From detection to direction: ctDNA-guided personalized therapy for muscle-invasive bladder cancer
Britt B. M. Suelmann, Michiel S. Van Der Heijden
Mar 01, 2026
pp. 155-156
10.1038/s41571-025-01113-y
When ctDNA says ‘maybe’: improving the dynamics of MRD trials
Julien Taieb
Mar 01, 2026
pp. 153-154
10.1038/s41571-025-01111-0
All Issues
Journal Info
Publisher
Springer Science and Business Media LLC
ISSN
1759-4774
E-ISSN
1759-4782
Subject
Medicine
Language
English